SlideShare a Scribd company logo
Motivational Interviewing to Improve Engagement
in Care and Adherence to Treatment1-3
Full abbreviations, accreditation, and disclosure information
available at PeerView.com/JDT40
1. https://aidsetc.org/sites/default/files/resources_files/MAAETC-%20Motivational_Interviewing2018.pdf. 2. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY:
Guilford Press; 2013. 3. Douaihy A, Gold MA, Kelly TM. Motivational Interviewing: A Guide for Medical Trainees. New York, NY: Oxford University Press; 2015.
• Motivational Interviewing is a goal-oriented style of communication involving use
of the language of change and collaboration between patient and healthcare
provider
• It is a practice empirically validated across diverse populations and for a wide
variety of target behaviors in the context of chronic medical conditions, diet and
exercise, drug and alcohol use, and treatment engagement and adherence
• It strengthens personal motivation for, and commitment to, specific goals
by exploring the person’s own reasons for change in an accepting and
compassionate atmosphere
Manage roadblocks to listening
Listen with the intent to understand
what the person is thinking, feeling,
and experiencing
Use more reflective listening to
engage the person
Normalize the person’s ambivalence
about change
Believe that change is within this
person’s own reach
Respect and support the person’s
autonomy and right to make decisions
Provide specific affirmations
Evoke the person’s reasons and
ideas for change
Summarize the person’s thoughts,
feelings, and experiences
Focus more on eliciting change talk
Ask permission to give feedback and
suggestions
Have in-depth discussions about the
person’s statements
Let roadblocks get in the way
of listening
Listen with the intent to reply
Use more questions to engage
the person
Ignore ambivalence and push
for change
Believe the person is not capable
of change
Convey that I am the expert and the
person must follow my advice
Use cheerleading
Impose reasons and ideas for change
Summarize my thoughts and
perspectives
Focus more on reinforcing sustain talk
Provide unsolicited feedback and
suggestions
Keep the conversation superficial
Do Don't
Rapid ART Restart1,2
Full abbreviations, accreditation, and disclosure information
available at PeerView.com/JDT40
• Immediate antiretroviral therapy (ART) refers to starting HIV treatment
as soon as possible after the diagnosis of HIV infection, preferably
on the first clinic visit (and even on the same day the HIV diagnosis is
made). This strategy also is known as "rapid ART," "same-day ART," and
"treatment upon diagnosis”
• Rapid ART is recommended by the Guidelines for the Use of Antiretroviral
Agents in Adults and Adolescents with HIV from the U.S. Department of
Health and Human Services to “increase the uptake of ART and linkage
to care, decrease time to viral suppression for individual patients, and
improve the rate of virologic suppression among persons with HIV”
• Nearly all PWH who are re-engaging
in care
• PWH for whom the ART history is
known, and HIV resistance is known
or can be predicted
• An appropriate ART regimen can
be devised without information from
current resistance test results
• HIV RNA (viral load)
• CD4 cell count
• HIV resistance test
• Creatine, liver transaminases
• Other tests if not previously done
• Persons with certain untreated
opportunistic infections (OIs), such
as CNS OIs, for whom a short
period of treatment for the OI is
recommended before ART initiation
• An appropriate ART regimen cannot
be devised without information from
current resistance test results
Rapid ART Restart for Persons Returning to Care
• While a key goal of HIV care is for people with HIV (PWH) to achieve
continuous viral suppression on ART, many PWH may stop ART or fall out of
care for periods of time
• It is important to re-engage these patients in care at the earliest opportunity,
and to support them in restarting ART
Immediate ART Restart
Is Appropriate For
Immediate ART Restart
Is Not Appropriate For
Laboratory Testing
What Is
Rapid ART?
Rapid ART Restart1,2
Full abbreviations, accreditation, and disclosure information
available at PeerView.com/JDT40
1. https://aidsetc.org/sites/default/files/resources_files/ncrc-rapid-art-6-10-21_0.pdf. 2. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv.
ART Regimens for Rapid Restart
Regimens should be selected individually, based on the
patient’s specific HIV, ART, and resistance history; as well as
their comorbidities, tolerance of previous ARVs, adherence
challenges, and other factors
It is not possible to make recommendations for individual patients, but common ART
restart scenarios include
– The patient was taking a 1st or 2nd ART regimen and there is no suspected
resistance: can start one of the regimens for initial immediate ART or (unless
contraindications) can restart the patient’s previous regimen
– The patient has a known or suspected history of virologic failure with acquired
ART resistance: select the ART regimen based on the suspected resistance
mutations
– If there is concern for NRTI and/or NNRTI resistance, consider a boosted
protease inhibitor + 2 NRTIs ± an integrase inhibitor
– If there is concern for NRTI and/or INSTI resistance, consider a boosted
protease inhibitor + 2 NRTIs ± a second-generation NNRTI
– If more extensive resistance may be present, consider a multi-class regimen
with a boosted darunavir + an integrase inhibitor ± an NNRTI ± NRTIs ±
fostemsavir or other ARVs as indicated
Consult with an HIV expert!
Tool and Steps for Identifying Evidence-Based Interventions
for Retention and Re-Engagement of PLWH in Care1,2
Full abbreviations, accreditation, and disclosure information available at PeerView.com/JDT40
1. https://wwwn.cdc.gov/HIVCompendium/SearchInterventions. 2. https://www.cdc.gov/hiv/research/interventionresearch/compendium/lrc/index.html.
The CDC provides a searchable Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention1
as well as a separate list of interventions for linkage to, retention in, and re-engagement in HIV care2
4. Assemble
a team with
assigned roles
3. Select a plan that
will work for your situation
and clinical program
1. Enter your targeted
population
2. Enter your desired
effects or outcomes
5. Implement
the intervention
6. Collect data 7. Evaluate 8. Adjust
9. Repeat
as needed

More Related Content

Similar to Road Map to Re-Engagement: A Visual Guide to Overcoming Individual and Systemic Barriers to HIV Care and Treatment

MedicalResearch.com: Medical Research Exclusive Interviews February 10 2015
MedicalResearch.com:  Medical Research Exclusive Interviews February 10  2015MedicalResearch.com:  Medical Research Exclusive Interviews February 10  2015
MedicalResearch.com: Medical Research Exclusive Interviews February 10 2015
Marie Benz MD FAAD
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiatDavid Ngogoyo
 
Patient Centred Medical Home as an enabler to more effective transitions of care
Patient Centred Medical Home as an enabler to more effective transitions of carePatient Centred Medical Home as an enabler to more effective transitions of care
Patient Centred Medical Home as an enabler to more effective transitions of care
Paresh Dawda
 
MedicalResearch.com - Medical Research Week in Review
MedicalResearch.com - Medical Research  Week in ReviewMedicalResearch.com - Medical Research  Week in Review
MedicalResearch.com - Medical Research Week in Review
Marie Benz MD FAAD
 
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENTJOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
Pristyn Research Solutions
 
NYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIV
NYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIVNYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIV
NYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIV
HIV Clinical Guidelines Program
 
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
hivlifeinfo
 
health maintenance
 health maintenance  health maintenance
health maintenance
Basma Mohamed Abd El Aziz
 
Treatment aspects : Pre/Post Operative Care & Pharmacological Aspects
Treatment aspects : Pre/Post Operative Care & Pharmacological AspectsTreatment aspects : Pre/Post Operative Care & Pharmacological Aspects
Treatment aspects : Pre/Post Operative Care & Pharmacological Aspects
KHyati CHaudhari
 
Antiretroviral Medication Adherence
Antiretroviral Medication AdherenceAntiretroviral Medication Adherence
Antiretroviral Medication AdherenceCDC NPIN
 
JCI __NABH_Hospital Standards_
JCI  __NABH_Hospital Standards_JCI  __NABH_Hospital Standards_
JCI __NABH_Hospital Standards_
Dr. Ranjan Ghosh
 
Seminar on ethics committee, cultural concerns
Seminar on ethics committee, cultural concernsSeminar on ethics committee, cultural concerns
Seminar on ethics committee, cultural concerns
Priyanka Tambe
 
Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...
Health Catalyst
 
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
Arbeena Shakir
 
C04 P02 CRITERIA FOR SCREENING TESTS.ppt
C04 P02 CRITERIA FOR SCREENING TESTS.pptC04 P02 CRITERIA FOR SCREENING TESTS.ppt
C04 P02 CRITERIA FOR SCREENING TESTS.ppt
sanakhader3
 
How pharmaceutical companies in India can provide Information therapy
How pharmaceutical companies in India can provide Information therapy  How pharmaceutical companies in India can provide Information therapy
How pharmaceutical companies in India can provide Information therapy
Dr Aniruddha Malpani
 
Diagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfDiagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfusapuka
 
How evidence affects clinical practice in egypt
How evidence affects clinical practice in egyptHow evidence affects clinical practice in egypt
How evidence affects clinical practice in egypt
Wafaa Benjamin
 
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...
PVI, PeerView Institute for Medical Education
 

Similar to Road Map to Re-Engagement: A Visual Guide to Overcoming Individual and Systemic Barriers to HIV Care and Treatment (20)

MedicalResearch.com: Medical Research Exclusive Interviews February 10 2015
MedicalResearch.com:  Medical Research Exclusive Interviews February 10  2015MedicalResearch.com:  Medical Research Exclusive Interviews February 10  2015
MedicalResearch.com: Medical Research Exclusive Interviews February 10 2015
 
03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat03.02 management of patients on antiretroviral drugs initiat
03.02 management of patients on antiretroviral drugs initiat
 
Patient Centred Medical Home as an enabler to more effective transitions of care
Patient Centred Medical Home as an enabler to more effective transitions of carePatient Centred Medical Home as an enabler to more effective transitions of care
Patient Centred Medical Home as an enabler to more effective transitions of care
 
MedicalResearch.com - Medical Research Week in Review
MedicalResearch.com - Medical Research  Week in ReviewMedicalResearch.com - Medical Research  Week in Review
MedicalResearch.com - Medical Research Week in Review
 
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENTJOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
 
NYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIV
NYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIVNYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIV
NYSDOH AI Rapid Initiation of Antiretroviral Therapy (ART) for Patients with HIV
 
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
 
health maintenance
 health maintenance  health maintenance
health maintenance
 
Use your Pharmacist Huentelman
Use your Pharmacist HuentelmanUse your Pharmacist Huentelman
Use your Pharmacist Huentelman
 
Treatment aspects : Pre/Post Operative Care & Pharmacological Aspects
Treatment aspects : Pre/Post Operative Care & Pharmacological AspectsTreatment aspects : Pre/Post Operative Care & Pharmacological Aspects
Treatment aspects : Pre/Post Operative Care & Pharmacological Aspects
 
Antiretroviral Medication Adherence
Antiretroviral Medication AdherenceAntiretroviral Medication Adherence
Antiretroviral Medication Adherence
 
JCI __NABH_Hospital Standards_
JCI  __NABH_Hospital Standards_JCI  __NABH_Hospital Standards_
JCI __NABH_Hospital Standards_
 
Seminar on ethics committee, cultural concerns
Seminar on ethics committee, cultural concernsSeminar on ethics committee, cultural concerns
Seminar on ethics committee, cultural concerns
 
Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...Precise Patient Registries: The Foundation for Clinical Research & Population...
Precise Patient Registries: The Foundation for Clinical Research & Population...
 
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
 
C04 P02 CRITERIA FOR SCREENING TESTS.ppt
C04 P02 CRITERIA FOR SCREENING TESTS.pptC04 P02 CRITERIA FOR SCREENING TESTS.ppt
C04 P02 CRITERIA FOR SCREENING TESTS.ppt
 
How pharmaceutical companies in India can provide Information therapy
How pharmaceutical companies in India can provide Information therapy  How pharmaceutical companies in India can provide Information therapy
How pharmaceutical companies in India can provide Information therapy
 
Diagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdfDiagnosis Of Hep C Update Aug%20 09pdf
Diagnosis Of Hep C Update Aug%20 09pdf
 
How evidence affects clinical practice in egypt
How evidence affects clinical practice in egyptHow evidence affects clinical practice in egypt
How evidence affects clinical practice in egypt
 
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...
Aligning Nursing Care Strategies With Evolving Patient Needs in RCC: Interpro...
 

More from PVI, PeerView Institute for Medical Education

Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
PVI, PeerView Institute for Medical Education
 
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
PVI, PeerView Institute for Medical Education
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
PVI, PeerView Institute for Medical Education
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
PVI, PeerView Institute for Medical Education
 
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
PVI, PeerView Institute for Medical Education
 
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
PVI, PeerView Institute for Medical Education
 
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
PVI, PeerView Institute for Medical Education
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
PVI, PeerView Institute for Medical Education
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
PVI, PeerView Institute for Medical Education
 
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
PVI, PeerView Institute for Medical Education
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
PVI, PeerView Institute for Medical Education
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
PVI, PeerView Institute for Medical Education
 
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
PVI, PeerView Institute for Medical Education
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
PVI, PeerView Institute for Medical Education
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
PVI, PeerView Institute for Medical Education
 
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
PVI, PeerView Institute for Medical Education
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
PVI, PeerView Institute for Medical Education
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
PVI, PeerView Institute for Medical Education
 
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
PVI, PeerView Institute for Medical Education
 
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
PVI, PeerView Institute for Medical Education
 

More from PVI, PeerView Institute for Medical Education (20)

Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
 
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
 
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
 
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
 
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
 
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
On Target: Understanding the Impact of PSMA for Diagnostic and Therapeutic St...
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
 
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
Harnessing Innovation in Bladder Cancer Care: Strategies for Effectively Impl...
 
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
Striking Back at ALL: Achieving Lasting Benefits with Bispecific Antibodies &...
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
 
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
Specialty Training for the New Era in Alzheimer’s Disease: Building Skills fo...
 
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
Ten Steps for Highly Successful Myeloma Care: Guidance on the Road to Remissi...
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...
 
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...
 
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 

Road Map to Re-Engagement: A Visual Guide to Overcoming Individual and Systemic Barriers to HIV Care and Treatment

  • 1. Motivational Interviewing to Improve Engagement in Care and Adherence to Treatment1-3 Full abbreviations, accreditation, and disclosure information available at PeerView.com/JDT40 1. https://aidsetc.org/sites/default/files/resources_files/MAAETC-%20Motivational_Interviewing2018.pdf. 2. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York, NY: Guilford Press; 2013. 3. Douaihy A, Gold MA, Kelly TM. Motivational Interviewing: A Guide for Medical Trainees. New York, NY: Oxford University Press; 2015. • Motivational Interviewing is a goal-oriented style of communication involving use of the language of change and collaboration between patient and healthcare provider • It is a practice empirically validated across diverse populations and for a wide variety of target behaviors in the context of chronic medical conditions, diet and exercise, drug and alcohol use, and treatment engagement and adherence • It strengthens personal motivation for, and commitment to, specific goals by exploring the person’s own reasons for change in an accepting and compassionate atmosphere Manage roadblocks to listening Listen with the intent to understand what the person is thinking, feeling, and experiencing Use more reflective listening to engage the person Normalize the person’s ambivalence about change Believe that change is within this person’s own reach Respect and support the person’s autonomy and right to make decisions Provide specific affirmations Evoke the person’s reasons and ideas for change Summarize the person’s thoughts, feelings, and experiences Focus more on eliciting change talk Ask permission to give feedback and suggestions Have in-depth discussions about the person’s statements Let roadblocks get in the way of listening Listen with the intent to reply Use more questions to engage the person Ignore ambivalence and push for change Believe the person is not capable of change Convey that I am the expert and the person must follow my advice Use cheerleading Impose reasons and ideas for change Summarize my thoughts and perspectives Focus more on reinforcing sustain talk Provide unsolicited feedback and suggestions Keep the conversation superficial Do Don't
  • 2. Rapid ART Restart1,2 Full abbreviations, accreditation, and disclosure information available at PeerView.com/JDT40 • Immediate antiretroviral therapy (ART) refers to starting HIV treatment as soon as possible after the diagnosis of HIV infection, preferably on the first clinic visit (and even on the same day the HIV diagnosis is made). This strategy also is known as "rapid ART," "same-day ART," and "treatment upon diagnosis” • Rapid ART is recommended by the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV from the U.S. Department of Health and Human Services to “increase the uptake of ART and linkage to care, decrease time to viral suppression for individual patients, and improve the rate of virologic suppression among persons with HIV” • Nearly all PWH who are re-engaging in care • PWH for whom the ART history is known, and HIV resistance is known or can be predicted • An appropriate ART regimen can be devised without information from current resistance test results • HIV RNA (viral load) • CD4 cell count • HIV resistance test • Creatine, liver transaminases • Other tests if not previously done • Persons with certain untreated opportunistic infections (OIs), such as CNS OIs, for whom a short period of treatment for the OI is recommended before ART initiation • An appropriate ART regimen cannot be devised without information from current resistance test results Rapid ART Restart for Persons Returning to Care • While a key goal of HIV care is for people with HIV (PWH) to achieve continuous viral suppression on ART, many PWH may stop ART or fall out of care for periods of time • It is important to re-engage these patients in care at the earliest opportunity, and to support them in restarting ART Immediate ART Restart Is Appropriate For Immediate ART Restart Is Not Appropriate For Laboratory Testing What Is Rapid ART?
  • 3. Rapid ART Restart1,2 Full abbreviations, accreditation, and disclosure information available at PeerView.com/JDT40 1. https://aidsetc.org/sites/default/files/resources_files/ncrc-rapid-art-6-10-21_0.pdf. 2. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv. ART Regimens for Rapid Restart Regimens should be selected individually, based on the patient’s specific HIV, ART, and resistance history; as well as their comorbidities, tolerance of previous ARVs, adherence challenges, and other factors It is not possible to make recommendations for individual patients, but common ART restart scenarios include – The patient was taking a 1st or 2nd ART regimen and there is no suspected resistance: can start one of the regimens for initial immediate ART or (unless contraindications) can restart the patient’s previous regimen – The patient has a known or suspected history of virologic failure with acquired ART resistance: select the ART regimen based on the suspected resistance mutations – If there is concern for NRTI and/or NNRTI resistance, consider a boosted protease inhibitor + 2 NRTIs ± an integrase inhibitor – If there is concern for NRTI and/or INSTI resistance, consider a boosted protease inhibitor + 2 NRTIs ± a second-generation NNRTI – If more extensive resistance may be present, consider a multi-class regimen with a boosted darunavir + an integrase inhibitor ± an NNRTI ± NRTIs ± fostemsavir or other ARVs as indicated Consult with an HIV expert!
  • 4. Tool and Steps for Identifying Evidence-Based Interventions for Retention and Re-Engagement of PLWH in Care1,2 Full abbreviations, accreditation, and disclosure information available at PeerView.com/JDT40 1. https://wwwn.cdc.gov/HIVCompendium/SearchInterventions. 2. https://www.cdc.gov/hiv/research/interventionresearch/compendium/lrc/index.html. The CDC provides a searchable Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention1 as well as a separate list of interventions for linkage to, retention in, and re-engagement in HIV care2 4. Assemble a team with assigned roles 3. Select a plan that will work for your situation and clinical program 1. Enter your targeted population 2. Enter your desired effects or outcomes 5. Implement the intervention 6. Collect data 7. Evaluate 8. Adjust 9. Repeat as needed